Bioactive Compounds
-
A1832 Doxorubicin (Adriamycin) HCl9 CitationTarget: TopoisomerasesSummary: DNA topoisomerase II inhibitor -
A1402 Gemcitabine HClSummary: Inhibits DNA synthesis,deoxycytidine analog -
A2149 Bosutinib (SKI-606)1 CitationTarget: Bcr-Abl|SrcSummary: Potent Abl/Src kinases -
A2067 PI-1031 CitationSummary: Class I PI3K, mTOR and DNA-PK inhibitor -
A2960 LoratadineTarget: Histamine H1 ReceptorsSummary: Peripheral HH1R antagonist -
A2307 PHA-6657521 CitationTarget: c-METSummary: C-Met inhibitor,potent and ATP-competitive -
A2942 Masitinib (AB1010)Target: PDGFR|c-Kit|LynSummary: Tyrosine kinase inhibitor, potent and selective -
A2036 Doripenem HydrateTarget: AntibioticSummary: Injectable antibiotic,ultra-broad spectrum -
A1389 WZ4002Summary: Mutant-selective EGFR inhibitor(L858R,T790M), irreversible and potent -
A1980 SNS-032 (BMS-387032)2 CitationTarget: Cyclin-Dependent KinasesSummary: CDK inhibitor

